Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statins

OBJECTIVE: Statins are sometimes associated with worsened glycemic control. Patients with type 2 diabetes mellitus (T2DM) may require non-statin therapies to achieve low-density lipoprotein cholesterol (LDL-C) lowering goals. This study evaluated the efficacy and safety of bempedoic acid 180 mg plus...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold E., Baum, Seth J., Brinton, Eliot A., Plutzky, Jorge, Hanselman, Jeffrey C., Teng, Rujun, Ballantyne, Christie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550983/
https://www.ncbi.nlm.nih.gov/pubmed/34746903
http://dx.doi.org/10.1016/j.ajpc.2021.100278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550983/
https://www.ncbi.nlm.nih.gov/pubmed/34746903
http://dx.doi.org/10.1016/j.ajpc.2021.100278

Ejemplares similares